true
BD sustainability in medication delivery
- Overview
- Manufacturing
- Product Design
- Outcomes
BD provides a broad range of medication delivery products, including vascular access systems and tools that support medication preparation and administration. BD medication delivery solutions are used across healthcare settings worldwide, shaping daily clinical workflows.
A commitment to advancing human health also includes a responsibility to reduce environmental impact.
BD is committed to reaching net zero greenhouse gas emissions by 2050, and our medication delivery solutions contribute to this effort. Spanning product lifecycles, manufacturing, supply chain partnerships and collaboration with healthcare organizations, our approach is designed to support care across the continuum. These end-to-end solutions are strategies to help reduce the risk of IV catheter-related infections and complications, streamline care, improve patient outcomes and advance healthcare worker and patient safety.
Three focus areas that guide this work:
-
Reducing environmental impact across global manufacturing
Manufacturing
-
Designing products with environmental considerations
Product Design
-
Supporting sustainable care pathways
Outcomes
Working together toward sustainable healthcare
BD partners with hospitals, procurement teams, and public agencies to incorporate environmental considerations into purchasing and tender processes—through responsible operations, product and packaging design considerations and collaboration across the value chain.
This shared effort supports progress toward sustainability objectives while maintaining focus on high-quality patient care for the communities served.
- Becton, Dickinson and Company. FY 2025 Corporate Sustainability Report: Together We Advance. Franklin Lakes, NJ: Becton, Dickinson and Company; 2026
Reducing environmental impact across global manufacturing
Across BD’s medication delivery solutions manufacturing network, teams run site-level projects that support sustainability. Sites focus on what matters most for their operations with emphasis on:
- Lowering energy demand.
- Improving operational efficiency.
- Increasing the use of renewable energy sources.
Sites identify projects based on local conditions. Each site tracks progress locally, including operational emissions (Scopes 1 and 2), where measured.
United States, Connecticut, Canaan
In 2024, the BD Canaan manufacturing plant:
- Reduced energy consumption by 10% (absolute) from a 2019 baseline.
- Reduced water usage by 17% (absolute) from a 2019 baseline.
- Reduced generation of non-hazardous waste by 17% (absolute) from a 2019 baseline.
- Diverted 100% of non-hazardous waste from landfill.
- Recycled 83% of non-hazardous waste produced on-site.
- Reduced generation of hazardous and controlled waste by 44% (absolute) from a 2019 baseline.
- Implemented an ISO 14001-certified environmental management system.2
United States, Nebraska, Columbus
In 2024, the BD Columbus West manufacturing plant:
- Reduced Scopes 1 and 2 GHG emissions by 47% (absolute) from a 2019 baseline.
- Sourced 34% of power from renewable sources.
- Recycled 82% of non-hazardous waste produced on-site.
- Implemented an ISO 14001-certified environmental management system.
United States, Utah, Sandy
In 2024, the BD Sandy manufacturing plant:
- Recycled 53% of non-hazardous waste produced on-site.
- Implemented an ISO 14001-certified environmental management system.
Brazil, Minas Gerais, Juiz de Fora
In 2024, the BD Juiz de Fora manufacturing plant:
- Reduced Scopes 1 and 2 GHG emissions by 36% (absolute) from a 2019 baseline.
- Reduced water usage by 14% (absolute) from a 2019 baseline.
- Recycled 54% of non-hazardous waste produced on-site.
- Reduced generation of hazardous and controlled waste by 17% (absolute) from a 2019 baseline.
- Implemented an ISO 14001-certified environmental management system.
Brazil, Paraná, Curitiba
In 2024, the BD Curitiba manufacturing plant:
- Reduced Scopes 1 and 2 GHG emissions by 36% (absolute) from a 2019 baseline.
- Reduced energy consumption by 17% (absolute) from a 2019 baseline.
- Reduced water usage by 51% (absolute) from a 2019 baseline.
- Reduced generation of non-hazardous waste by 40% (absolute) from a 2019 baseline.
- Diverted 97% of non-hazardous waste from landfill.
- Recycled 96% of non-hazardous waste produced on-site.
- Implemented an ISO 14001-certified environmental management system.
Mexico, Baja California, Tijuana
In 2024, the BD Tijuana MDS manufacturing plant:
- Reduced Scopes 1 and 2 GHG emissions by 26% (absolute) from a 2019 baseline.
- Reduced energy consumption by 13% (absolute) from a 2019 baseline.
- Reduced water usage by 16% (absolute) from a 2019 baseline.
- Reduced generation of non-hazardous waste by 14% (absolute) from a 2019 baseline.
- Recycled 90% of non-hazardous waste produced on-site.
- Implemented an ISO 14001-certified environmental management system.
Mexico, San Luis Potosí, San Luis Potosí
In 2024, the BD San Luis Potosí manufacturing plant:
- Reduced Scopes 1 and 2 GHG emissions by 25% (absolute) from a 2019 baseline.
- Reduced energy consumption by 12% (absolute) from a 2019 baseline.
- Reduced water usage by 51% (absolute) from a 2019 baseline.
- Implemented an ISO 14001-certified environmental management system.
Mexico, Sonora, Nogales
In 2024, the BD Nogales manufacturing plant:
- Reduced Scopes 1 and 2 GHG emissions by 68% (absolute) from a 2019 baseline.
- Sourced 66% of power from renewable sources.
- Has implemented an ISO 14001-certified environmental management system.
Bosnia and Herzegovina, Una Sana Canton, Cazin
In 2024, the BD Cazin manufacturing plant:
- Reduced water usage by 6% (absolute) from a 2019 baseline.
- Reduced generation of hazardous and controlled waste by 71% (absolute) from a 2019 baseline.
- Implemented an ISO 14001-certified environmental management system.
Spain, Aragon, Fraga
In 2024, the BD Fraga manufacturing plant:
- Reduced Scopes 1 and 2 GHG emissions by 9% (absolute) from a 2019 baseline.
- Used 100% green electric power.
- Diverted 99% of non-hazardous waste from landfill.
- Recycled 88% of non-hazardous waste produced on-site.
- Implemented an ISO 14001-certified environmental management system.
- Implemented an ISO 50001-certified energy management system.
Spain, Community of Madrid, San Agustin de Guadalix
In 2024, the BD San Agustin manufacturing plant:
- Reduced Scopes 1 and 2 GHG emissions by 83% (absolute) from a 2019 baseline.
- Used 100% green electric power.
- Recycled 86% of non-hazardous waste produced on-site.
- Implemented an ISO 14001-certified environmental management system.3
Spain, Extremadura, Almaraz
In 2024, the BD Almaraz manufacturing plant:
- Reduced Scopes 1 and 2 GHG emissions by 82% (absolute) from a 2019 baseline.
- Reduced energy consumption by 9% (absolute) from a FY 2019 baseline.
- Sourced 76% of power from renewable sources.
- Used 100% green electric power.
- Reduced generation of non-hazardous waste by 11% (absolute) from a 2019 baseline.
- Recycled 50% of non-hazardous waste produced on-site.
- Implemented an ISO 14001-certified environmental management system.
China, Jiangsu, Suzhou
In 2024, the BD Suzhou MDS manufacturing plant:
- Sourced 13% of power from renewable sources.
- Reduced generation of non-hazardous waste by 33% (absolute) from a 2019 baseline.
- Diverted 100% of non-hazardous waste from landfill.
- Reduced generation of hazardous and controlled waste by 38% (absolute) from a 2019 baseline.
- Implemented an ISO 14001-certified environmental management system.
India, Haryana, Bawal
In 2024, the BD India manufacturing plant:
- Increased generation of renewable power from on-site solar by 33% from a 2019 baseline.
- Reduced generation of non-hazardous waste by 18% (absolute) from a 2019 baseline.
- Diverted 100% of non-hazardous waste from landfill.
- Implemented an ISO 14001-certified environmental management system.
Singapore, West Region, Tuas
In 2024, the BD Tuas manufacturing plant:
- Reduced Scopes 1 and 2 GHG emissions by 7% (absolute) from a 2019 baseline.
- 7% of power used was generated from on-site solar.
- Reduced water usage by 26% (absolute) from a 2019 baseline.
- Reduced generation of non-hazardous waste by 11% (absolute) from a 2019 baseline.
- Recycled 34% of non-hazardous waste produced on-site.
- Implemented an ISO 14001-certified environmental management system.
REF-96206 bd-sustainability-report-2025 (v0.1)
- Becton, Dickinson and Company. FY 2025 Corporate Sustainability Report: Together We Advance. Franklin Lakes, NJ: Becton, Dickinson and Company; 2026.
- Becton, Dickinson and Company. Environmental Management Systems. Updated February 23, 2026. Accessed August 27, 2026.
- Becton Dickinson, SA. ISO 14001:2015 Environmental Management System Certificate, San Agustín de Guadalix, Madrid, Spain. AENOR; issued December 15, 2024. Valid through December 15, 2027.
Designing products with environmental considerations
Environmental impact is influenced by every stage of a product’s lifecycle. BD integrates sustainability principles into the development of medication delivery products and packaging by:*
- Evaluating material choices.
- Exploring opportunities to optimise design efficiency.
- Identifying ways to reduce packaging volume.
- Considering lower‑impact alternatives where feasible.
- Evaluating regional production and supplier proximity, where feasible, to limit transport distances.
These efforts reflect an ongoing commitment to incorporate environmental considerations into future solutions while maintaining alignment with clinical needs and regulatory requirements.
*Potential environmental benefit varies by product, logistics profile, local energy sources and packaging efficiency.
Addressing environmental impact in practice:
- Regional manufacturing
PosiFlush™ Syringes are manufactured in Fraga, Spain. Regional European production supports shorter transport distances for our European customers.
- Environmental management systems
ISO 14001-certified environmental management systems are implemented at manufacturing sites. As of 2022, 46 BD sites hold ISO 14001 certification, including PosiFlush™ Syringe manufacturing sites.
- On‑site energy
Combined Heat and Power (CHP) units are installed at the Fraga facility to provide on‑site heat and power for operations.1
- Recyclable packaging
Shelf cartons are made from 100% recyclable material.*
*Recycling availability depends on local programs and facilities.
- Volume options
Smaller volume options (3 mL and 5 mL) are available. Selecting an appropriate volume may support material efficiency and waste reduction objectives, depending on clinical practice.
At BD, we believe that integrity, respect and accountability are the core principles of sustainable and responsible business. These principles guide us as we continue to grow and innovate, ensuring that we uphold the highest standards of ethical conduct—not only within our own operations,2 but across our entire supply chain.3 Sourcing from European manufacturers supports supply chain resilience and faster delivery.4
Production: Fraga, Spain
- Lower transport footprint.
- Faster deliveries.
- Less risk of supply disruptions.
- Less risk of temperature excursion on long run transportation lead-times.
- In line with Regulations (EU) 2025/1197 to support European manufacturing.
- Powered by 100% renewable electricity.8
BD Emerald" Syringes are designed with attention to materials, packaging and the energy used in production, which helps lower environmental impact while still meeting quality and regulatory expectations. They use up to 30% less material than other syringes6 and still meet our highest standards for product performance.
- Latex, di-2-ethylhexyl phthalate (DEHP), Polyvinyl chloride (PVC), Bisphenol A (BPA), or animal tissue are not part of the material formulation.7
- Reduced number of materials5 and recyclable packaging.
- Every component meets ISO 10993 series requirements for biocompatibility.3
- Manufactured in a facility with ISO 14001-certified environmental management system.
- Manufactured at a facility that is powered by 100% renewable electricity.8
Peripheral Intravenous Catheter that last longer and fail less help reduce reinsertions, complications and overall cost of care. Better performance also means less waste, which supports value-based care and sustainability goals.
- BD® Nexiva Closed IV Catheter System with BD® MaxZero Needle-free Connector combines the PIVC, extension set and needle-free connector in one package. Nexiva has been clinically shown to deliver up to 50% longer dwell time and reduced complications, which can lead to less material waste.9,10
- Proprietary BD Vialon™ Catheter Material enables longer catheter dwell times, up to 144 hours. Replacing a PIVC less often could lead to less wasted catheters.9,11
- Vialon Catheter Material has been clinically demonstrated to reduce phlebitis up to 69% compared to an fluorinated ethylene propylene catheter catheter material11-13 and 32% compared to a polyurethane catheter material catheter material.14
- Manufactured in a facility with ISO 14001-certified environmental management system.
- Manufactured at a facility that is powered by 66% renewable electricity.
Please consult BD product labels and inserts relevant to your geography for any indications, contraindications, hazards, warnings, cautions and instructions for use. Any discussion and/or content regarding BD products is limited to this information and instructions for use.
- Office of Energy Efficiency and Renewable Energy. Advanced Manufacturing & Industrial Decarbonization. Combined Heat and Power Basics. U.S. Department of Energy. https://www.energy.gov/eere/amo/combined-heat-and-power-basics. Accessed September 2, 2026.
- Becton, Dickinson and Company. BD Code of Conduct. BD. Accessed September 2, 2026. https://www.bd.com/en-us/about-bd/policies/bd-code-of-conduct
- Becton, Dickinson and Company. Expectations for Suppliers. BD. Accessed September 2, 2026. https://www.bd.com/en-us/about-bd/policies/expectations-for-suppliers-page
- V201‑015 — Rev. 04 Technical Data Sheet BD‑132095 PosiFlush Syringes 10 facts.
- Becton, Dickinson and Company (BD). FY 2020 Sustainability Report. (2020). Accessed on September 8, 2021 at https://www.bd.com/documents/corporate/BD_Sustainabilityreport-2020_EN.pdf.
- BD Data on File. REF-72629. Memo to Support BD Emerald Syringe Claim. CS-006974.pdf. Accessed September 2, 2026.
- Technical Data Sheet V201-005 Rev. 07 for BD Emerald™ Syringes with and without Needle, Sterile, Europe, June 2021.
- BD Data on File, green support file - metric tonnes CO2e-saved. Internal Emerald green report, April 2022.
- Bausone-Gazda D, Lefaiver CA, Walters SA. A randomized controlled trial to compare the complications of 2 peripheral intravenous catheter-stabilization systems. J Infus Nurs. 2010;33(6):371-384.
- González López J, Arribi Vilela A, Fernández Del Palacio E, et al. Indwell times, complications and costs of open vs closed safety peripheral intravenous catheters: a randomized study. J Hosp Infect. 2014;86(2):117-126.
- Kus B, Buyukyilmaz F. Effectiveness of Vialon biomaterial versus Teflon catheters for peripheral intravenous placement: A randomized clinical trial. Jpn J Nurs Sci. 2020;e12328. https://doi.org/10.1111/jjns.12328.
- Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. Annals of Internal Medicine. 1991;114:845-854.
- Gaukroger PB, Roberts JG, Manners TA. Infusion thrombophlebitis: a prospective comparison of 645 Vialon and Teflon cannulae in anaesthetic and postoperative use. Anaesthesia and Intensive Care. 1988;16:265-271.
- Yasuda H, Rickard C, Marsh N, et al. Risk factors for peripheral intravascular catheter-related phlebitis in critically ill patients: analysis of 3429 catheters from 23 Japanese intensive care units. Annals of Intensive Care. 2022 12:33. https://doi.org/10.1186/s13613-022-010095-5.
How environmental stability and improved clinical outcomes can go hand-in-hand
BD is focused on improving vascular access care which can improve environmental impact. External research and BD modeling suggest that optimizing elements of the vascular access pathway can be associated with carbon reductions of up to ~1,000 kg CO₂ per patient pathway, depending on local practice and system‑level decisions. By aligning evidence‑based care with sustainability priorities, BD Vascular Access Management (VAM) supports both improved clinical outcomes and more resource‑efficient healthcare.1,2
We work with hospitals, procurement teams and public agencies, sharing practice insights, education and tools to review current approaches.
Support includes:
- Sharing clinical practice insights.
- Providing educational resources and training.
- Assessing current practice with practical tools and feedback to improve care.
For additional materials, pathway overviews, resource libraries, events and partnership options, see the Vascular Access Management resource hub.
- Drugeon B, Guenezan J, Pichon M, et al. Incidence, complications, and costs of peripheral venous catheter-related bacteraemia: a retrospective, singlecentre study. J Hosp Infect. 2023;135:67-73. doi:10.1016/j.jhin.2023.02.012.
- Tennison I, Roschnik S, Ashby B, et al. Health care's response to climate change: a carbon footprint assessment of the NHS in England. Lancet Planet Health. 2021;5(2):e84-e92. doi:10.1016/S2542-5196(20)30271-0.
true
